|
Delayed
NYSE
23:00:00 05/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.200 USD | +2.56% |
|
+1.69% | -11.76% |
| 08-15 | Actinium Pharmaceuticals Expands Manufacturing Capacity for Actimab-A Program | CI |
| 08-15 | Actinium Pharmaceuticals, Inc. Amends Its Investigational New Drug | CI |
| Market Cap | 37.73M 33.66M 31.36M 28.54M 53.74M 3.63B 54.14M 379M 147M 1.85B 142M 139M 5.96B | P/E 2026 * |
6.79x | P/E 2027 * | -1.79x |
|---|---|---|---|---|---|
| Enterprise Value | 37.73M 33.66M 31.36M 28.54M 53.74M 3.63B 54.14M 379M 147M 1.85B 142M 139M 5.96B | EV / Sales 2026 * |
2.16x | EV / Sales 2027 * | - |
| Free-Float |
91.92% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| ATNM | Delayed | |
CBOE
| ATNM | Real-time | |
Tradegate
| 7AY1 | Real-time | |
Deutsche Boerse AG
| 7AY1 | Delayed | |
Börse Stuttgart
| 7AY1 | Delayed | |
Boerse Muenchen
| 7AY1 | Real-time |
| 1 day | +2.56% | ||
| 1 week | +1.69% | ||
| Current month | +7.14% | ||
| 1 month | +16.50% | ||
| 3 months | +22.32% | ||
| 6 months | +22.40% | ||
| Current year | -11.76% |
| 1 week | 1.1 | 1.24 | |
| 1 month | 1.06 | 1.42 | |
| Current year | 0.74 | 1.53 | |
| 1 year | 0.74 | 1.74 | |
| 3 years | 0.74 | 10.24 | |
| 5 years | 0.74 | 15.12 | |
| 10 years | 0.74 | 51.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sandesh Seth
CEO | Chief Executive Officer | 62 | 09/06/2017 |
Steffen Heeger
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/2026 |
Adeela Kamal
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
C. Nicholson
BRD | Director/Board Member | 71 | 01/01/2008 |
Sandesh Seth
CHM | Chairman | 62 | 01/10/2013 |
| Director/Board Member | 68 | 08/11/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/3/26 A | Other | Chief Technology Officer | 333,648 | 1.0634% | ||
| 9/3/26 A | Other | Chief Technology Officer | 403,868 | 1.2872% | ||
| 9/2/26 A | Free | Director | 157,000 | 0.5004% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.56% | +1.69% | -24.05% | -80.26% | 37.73M | ||
| +4.16% | +3.42% | +49.37% | +94.17% | 74.31B | ||
| +0.62% | -3.47% | +20.48% | +75.15% | 56.95B | ||
| +2.30% | +1.03% | +5.89% | +37.53% | 48.3B | ||
| -1.07% | +2.94% | +344.62% | +722.17% | 44.51B | ||
| +2.36% | -1.80% | +28.78% | +34.51% | 43.8B | ||
| +0.90% | -1.46% | +5.17% | +111.90% | 41.12B | ||
| -0.54% | +2.41% | +9.31% | +58.85% | 31.07B | ||
| +4.51% | +8.22% | +37.86% | +32.49% | 28.97B | ||
| +1.83% | -1.45% | -7.44% | -11.12% | 24.53B | ||
| Average | +1.86% | -0.39% | +47.00% | +107.54% | 39.36B | |
| Weighted average by Cap. | +1.91% | -0.46% | +58.78% | +136.80% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 17.5M 15.61M 14.54M 13.24M 24.93M 1.69B 25.11M 176M 68.38M 860M 65.69M 64.28M 2.76B | - |
| Net income | 5.91M 5.27M 4.91M 4.47M 8.42M 569M 8.48M 59.37M 23.1M 291M 22.19M 21.71M 934M | -30.95M -27.61M -25.72M -23.41M -44.08M -2.98B -44.41M -311M -121M -1.52B -116M -114M -4.89B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/10/26 | $1.200 | +2.56% | 115,026 |
| 02/10/26 | $1.170 | +1.74% | 81,800 |
| 01/10/26 | $1.150 | +2.68% | 90,832 |
| 30/09/26 | $1.120 | -1.75% | 95,130 |
| 29/09/26 | $1.140 | -3.39% | 62,022 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ATNM Stock
Select your edition
All financial news and data tailored to specific country editions

















